# Penalty for violation related to drug samples resulting in a conviction of any representative of manufacturer or distributor after the second conviction in any 10-yr period — Federal civil penalty maximums — current inflation-adjusted amounts across agencies

For Penalty for violation related to drug samples resulting in a conviction of any representative of manufacturer or distributor after the second conviction in any 10-yr period, agency is HHS; statutory authority is 333(b)(2)(B); maximum penalty is 2,626,135, recorded from its source on 2026-08-10.

- **Agency:** HHS _(our reading, not quoted from the source)_
- **Violation:** Penalty for violation related to drug samples resulting in a conviction of any representative of manufacturer or distributor after the second conviction in any 10-yr period _(verified: appears in the quote below)_
- **Statutory authority:** 333(b)(2)(B) _(verified: appears in the quote below)_
- **Maximum penalty:** 2,626,135 _(verified: appears in the quote below)_

## What the source says

> 333(b)(2)(B) | | FDA | Penalty for violation related to drug samples resulting in a conviction of any representative of manufacturer or distributor after the second conviction in any 10-yr period | 2024 | 2,559,636 | 2,626,135

## Source

- https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-102/section-102.3

Last verified: 2026-08-10. Review by: 2027-02-26.
Part of [Federal civil penalty maximums — current inflation-adjusted amounts across agencies](https://referencesource.org/federal-civil-penalty-maximums/).